Search

everythinglearnresearchcommunity

for

Search:↓

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Vascular patterns in dermoscopy help tell apart malignant and benign skin tumors.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

3D-bioprinting models of pancreatic cancer could help personalize treatments but need more testing.

Older men and those with a history of skin cancer have a higher risk of getting skin cancer again.

The paper concludes that elderly in India face unique skin challenges and need better dermatological care and awareness.